Legend Biotech (LEGN) Shares Outstanding (Weighted Average) (2019 - 2025)
Legend Biotech (LEGN) posted Shares Outstanding (Weighted Average) of $100.0 billion for Q4 2025, up 13888888788.89% on a QoQ basis from $720.0 in Q3 2025, and up 99900.0% year-over-year from N/an in Q4 2024.
Legend Biotech (LEGN) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $100.0 billion in Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) rose 99900.0% year-over-year to $100.0 billion; the TTM figure through Dec 2025 stood at $100.0 billion (up 99900.0% YoY), while the FY2025 annual figure was $100.0 billion, up 99900.0% from the prior year.
- Shares Outstanding (Weighted Average) climbed to $100.0 billion in Q4 2025, from $720.0 in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $100.0 billion in Q4 2025 and bottomed at $210.0 in Q2 2024.
- A 5-year average of $5.6 billion and a median of $36.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) surged 1143229.76% — and 2024, when it tumbled 100.0%.
- Year by year, Shares Outstanding (Weighted Average) stood at $281.7 million in 2021, then gained by 12.91% to $318.1 million in 2022, then sank by 99.99% to $36000.0 in 2023, then surged by 277677.78% to $100.0 million in 2024, then jumped by 99900.0% to $100.0 billion in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $100.0 billion (Q4 2025), $720.0 (Q3 2025), and $620.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 198.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.00 Bn |
| Sep 30, 2025 | 37.00 Mn |
| Jun 30, 2025 | 620.00 |
| Mar 31, 2025 | 37.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 37.00 Mn |
| Jun 30, 2024 | 210.00 |
| Mar 31, 2024 | 36.00 Mn |
| Dec 31, 2023 | 36,000.00 |
| Sep 30, 2023 | 36.00 Mn |
| Jun 30, 2023 | 36.00 Mn |
| Mar 31, 2023 | 33.00 Mn |
| Dec 31, 2022 | 318.08 Mn |
| Mar 31, 2022 | 31.00 Mn |
| Dec 31, 2021 | 281.70 Mn |
| Sep 30, 2021 | 289.92 Mn |
| Jun 30, 2021 | 277.02 Mn |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | 236.31 Mn |
| Sep 30, 2020 | 26,000.00 |
| Jun 30, 2020 | 215.55 Mn |
| Mar 31, 2020 | 200.00 Mn |
| Dec 31, 2019 | 200.00 Mn |
| Sep 30, 2019 | 200.00 Mn |
| Jun 30, 2019 | 200.00 Mn |